Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma
- DOI
- 10.1186/s13046-021-02150-y
- Published
- 2021-12-02
- Container
- Journal of Experimental & Clinical Cancer Research
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13046-021-02150-y,
title = {Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma},
author = {Cinzia Lanzi and Enrica Favini and Laura Dal Bo and Monica Tortoreto and Noemi Arrighetti and Nadia Zaffaroni and Giuliana Cassinelli},
year = {2021},
journal = {Journal of Experimental \& Clinical Cancer Research},
doi = {10.1186/s13046-021-02150-y},
url = {https://doi.org/10.1186/s13046-021-02150-y}
}RIS
TY - JOUR TI - Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma AU - Cinzia Lanzi AU - Enrica Favini AU - Laura Dal Bo AU - Monica Tortoreto AU - Noemi Arrighetti AU - Nadia Zaffaroni AU - Giuliana Cassinelli PY - 2021 JO - Journal of Experimental & Clinical Cancer Research DO - 10.1186/s13046-021-02150-y UR - https://doi.org/10.1186/s13046-021-02150-y ER -
APA
Lanzi, C., Favini, E., Bo, L. D., Tortoreto, M., Arrighetti, N., Zaffaroni, N., & Cassinelli, G. (2021). Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-021-02150-y
Source records
- crossref · retrieved 2026-09-27T11:03:46.468Z